These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 21793016)

  • 1. Radiohalogenated nonnatural amino acids as PET and SPECT tumor imaging agents.
    McConathy J; Yu W; Jarkas N; Seo W; Schuster DM; Goodman MM
    Med Res Rev; 2012 Jul; 32(4):868-905. PubMed ID: 21793016
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synthesis and biological properties of radiohalogenated α,α-disubstituted amino acids for PET and SPECT imaging of amino acid transporters (AATs).
    Goodman MM; Yu W; Jarkas N
    J Labelled Comp Radiopharm; 2018 Mar; 61(3):272-290. PubMed ID: 29143354
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-natural amino acids for tumor imaging using positron emission tomography and single photon emission computed tomography.
    McConathy J; Goodman MM
    Cancer Metastasis Rev; 2008 Dec; 27(4):555-73. PubMed ID: 18648909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiolabeled amino acids for oncologic imaging.
    Huang C; McConathy J
    J Nucl Med; 2013 Jul; 54(7):1007-10. PubMed ID: 23708197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of Amino Acid-Based Radiopharmaceuticals for Tumor Imaging.
    Zhu J; Song X; Zhang J
    Mini Rev Med Chem; 2018; 18(7):561-583. PubMed ID: 27121713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fluorine-18 labeled amino acids for oncologic imaging with positron emission tomography.
    Huang C; McConathy J
    Curr Top Med Chem; 2013; 13(8):871-91. PubMed ID: 23590170
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiolabeled glucose derivatives for tumor imaging using SPECT and PET.
    Liu T; Zhang J; Wang X; Yang J; Tang Z; Lu J
    Curr Med Chem; 2014; 21(1):24-34. PubMed ID: 23992343
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single photon emission computed tomography and positron emission tomography in cancer imaging.
    Coleman RE
    Cancer; 1991 Feb; 67(4 Suppl):1261-70. PubMed ID: 1991287
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Applications of PET imaging of neurological tumors with radiolabeled amino acids.
    Galldiks N; Langen KJ
    Q J Nucl Med Mol Imaging; 2015 Mar; 59(1):70-82. PubMed ID: 25517079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (18)F-labeled positron emission tomographic radiopharmaceuticals in oncology: an overview of radiochemistry and mechanisms of tumor localization.
    Vallabhajosula S
    Semin Nucl Med; 2007 Nov; 37(6):400-19. PubMed ID: 17920348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis and preliminary biological evaluation of O-2((2-[(18)F]fluoroethyl)methylamino)ethyltyrosine ([(18)F]FEMAET) as a potential cationic amino acid PET tracer for tumor imaging.
    Chiotellis A; Müller A; Weyermann K; Leutwiler DS; Schibli R; Ametamey SM; Krämer SD; Mu L
    Amino Acids; 2014 Aug; 46(8):1947-59. PubMed ID: 24802247
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PET tracers in musculoskeletal disease beyond FDG.
    Wieder HA; Pomykala KL; Benz MR; Buck AK; Herrmann K
    Semin Musculoskelet Radiol; 2014 Apr; 18(2):123-32. PubMed ID: 24715445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular transport mechanisms of radiolabeled amino acids for PET and SPECT.
    Langen KJ; Bröer S
    J Nucl Med; 2004 Sep; 45(9):1435-6. PubMed ID: 15347708
    [No Abstract]   [Full Text] [Related]  

  • 14. 5-(2-18F-fluoroethoxy)-L-tryptophan as a substrate of system L transport for tumor imaging by PET.
    Krämer SD; Mu L; Müller A; Keller C; Kuznetsova OF; Schweinsberg C; Franck D; Müller C; Ross TL; Schibli R; Ametamey SM
    J Nucl Med; 2012 Mar; 53(3):434-42. PubMed ID: 22331220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical studies of SPECT and PET tracers for NET.
    Brom M; Boerman O; Gotthardt M; Oyen WJ
    PET Clin; 2014 Jan; 9(1):63-9. PubMed ID: 25029935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biological evaluation of 3-[(18)F]fluoro-α-methyl-D-tyrosine (D-[(18)F]FAMT) as a novel amino acid tracer for positron emission tomography.
    Ohshima Y; Hanaoka H; Tominaga H; Kanai Y; Kaira K; Yamaguchi A; Nagamori S; Oriuchi N; Tsushima Y; Endo K; Ishioka NS
    Ann Nucl Med; 2013 May; 27(4):314-24. PubMed ID: 23337966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PET with radiolabeled aminoacid.
    Crippa F; Alessi A; Serafini GL
    Q J Nucl Med Mol Imaging; 2012 Apr; 56(2):151-62. PubMed ID: 22617237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is there a role for PET-CT and SPECT-CT in pediatric oncology?
    Biermann M; Schwarzlmüller T; Fasmer KE; Reitan BC; Johnsen B; Rosendahl K
    Acta Radiol; 2013 Nov; 54(9):1037-45. PubMed ID: 23319723
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Miscellaneous cancers (lung, thyroid, renal cancer, myeloma, and neuroendocrine tumors): role of SPECT and PET in imaging bone metastases.
    Chua S; Gnanasegaran G; Cook GJ
    Semin Nucl Med; 2009 Nov; 39(6):416-30. PubMed ID: 19801221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid conjugates for nuclear imaging of folate receptor-positive cancer.
    Müller C; Schibli R
    J Nucl Med; 2011 Jan; 52(1):1-4. PubMed ID: 21149477
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.